Genmab | Der Umsatz



Sales Veränderung Datum
Agios Pharmaceuticals USD 12.45M 3.75M 2025-06
Almirall EUR 275M 9.6M 2025-06
Amarin USD 72.74M 30.72M 2025-06
Amgen USD 9.18B 1.03B 2025-06
argenx SE USD 842.5M 132.26M 2025-06
AstraZeneca USD 14.46B 867M 2025-06
Bayer EUR 10.74B 3B 2025-06
BioMarin Pharmaceutical USD 825M 80M 2025-06
Demant DKK 5.63B 10M 2025-06
Exelixis USD 568.3M 12.9M 2025-06
Fresenius Medical Care EUR 4.79B 90M 2025-06
Galapagos EUR 70.17M 4.81M 2025-06
Genmab DKK 5.86B 580M 2025-06
GlaxoSmithKline GBP 7.99B 470M 2025-06
GN Store Nord DKK 3.99B 1.03B 2025-03
GRIFOLS EUR 1.89B 100M 2025-06
Hikma Pharmaceutical USD 1.59B 18M 2024-12
Insmed USD 107.4M 14.58M 2025-06
Lonza CHF 3.58B 63M 2025-06
Merck EUR 4.43B 850M 2025-06
Novartis USD 14.05B 821M 2025-06
Regeneron Pharmaceuticals USD 3.68B 650M 2025-06
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 9.99B 90M 2025-06
UCB EUR 3.49B 129M 2025-06


Genmab Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.